Home-use electric stimulation chair (CGM MEPC-2401) to improve blood circulation
A Single-center, Open-label, Exploratory Clinical Trial to Evaluate the Safety and Efficacy of a Statics Electricity Generator for Electric Stimulation Home Use(CGM MEPC_2401) for Improving Blood Circulation
This trial tests whether using a personal electro-potential chair (Ceragem Celtron CGM MEPC-2401) can improve blood circulation in healthy adults aged 19–65.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 19 Years to 65 Years |
| Sex | All |
| Sponsor | Ceragem Inc. Industry-sponsored |
| Locations | 1 site (Wŏnju) |
| Trial ID | NCT07446088 on ClinicalTrials.gov |
What this trial studies
This single-center, open-label exploratory trial applies the Ceragem Celtron Circulation Chair (CGM MEPC-2401) to healthy adult volunteers to see if regular sessions improve blood circulation while monitoring safety. Eligible participants are adults 19–65 years old with BMI ≤30 and normal hematology results; people with implanted electronic devices, uncontrolled hypertension, seizure disorders, ventricular arrhythmias, or certain neurological conditions are excluded. Study staff will deliver the device intervention and collect physiological measures of circulation along with safety labs and adverse event monitoring. The goal is to characterize any circulatory changes and the safety profile of this personal electro-potential generator.
Who should consider this trial
Good fit: Healthy adults 19–65 years old with BMI ≤30 and normal CBC results, who do not have implanted electronic devices, seizure disorders, serious arrhythmias, uncontrolled hypertension, or certain neurological disorders.
Not a fit: People with pacemakers or other implanted devices, uncontrolled hypertension, seizure history, ventricular arrhythmias, neurological disorders like diabetic neuropathy, or those who require assistive medical devices are excluded and unlikely to benefit from this intervention in the trial.
Why it matters
Potential benefit: If successful, the device could offer a noninvasive, at-home way to improve peripheral blood flow for some people.
How similar studies have performed: Related forms of electrical stimulation have shown improvements in blood flow in some prior research, but the specific home-use chair device and its effects remain relatively untested and exploratory.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged between 19 and 65 years * Individuals with a BMI of 30.0 kg/m² or less * Individuals without abnormal findings on hematology tests (CBC) Exclusion Criteria: * Patients with uncontrolled hypertension despite medication (defined as systolic blood pressure ≥150 mmHg or diastolic blood pressure ≥100 mmHg measured at rest) * Patients with medical conditions requiring the use of assistive devices (e.g., pacemaker, artificial joint, stent, prosthesis, etc.) * Patients with seizure disorders or a history of loss of consciousness (e.g., epilepsy, acute febrile convulsions such as those associated with severe fever, etc.), or those at high risk of electric shock due to such conditions * Patients with ventricular arrhythmias (e.g., ventricular tachycardia, history of coronary artery bypass surgery, etc.) and patients with neurological disorders (e.g., diabetic neuropathy, etc.)
Where this trial is running
Wŏnju
- Wonju Severance Christian Hospital — Wŏnju, South Korea (Recruiting)
Study contacts
- Principal investigator: Kwang Yong Shim, MD — Wonju Severance Christian Hospital
- Study coordinator: Myeongbae Shin, Researcher
- Email: mbshin94@ceragem.com
- Phone: 82-10-4373-2808
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.